Drug lowers high potassium levels associated with potentially lethal cardiac arrhythmias

17 noviembre 2014

Researchers evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia — higher than normal potassium levels. Hyperkalemia is a common electrolyte disorder which can cause potentially life-threatening cardiac arrhythmias and is associated with chronic kidney disease, heart failure, and diabetes mellitus.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/gpj9yyuDP6M/141117084745.htm

Volver